McLaughlin J - Search Results

1

Alternative forms of the BCR-ABL oncogene have quantitatively different potencies for stimulation of immature lymphoid cells.

McLaughlin J, Chianese E, Witte ON. McLaughlin J, et al. Mol Cell Biol. 1989 May;9(5):1866-74. doi: 10.1128/mcb.9.5.1866-1874.1989. Mol Cell Biol. 1989. PMID: 2747638 Free PMC article.

2

Cell context-specific effects of the BCR-ABL oncogene monitored in hematopoietic progenitors.

Wong S, McLaughlin J, Cheng D, Witte ON. Wong S, et al. Among authors: mclaughlin j. Blood. 2003 May 15;101(10):4088-97. doi: 10.1182/blood-2002-11-3376. Epub 2003 Jan 9. Blood. 2003. PMID: 12521991 Free article.

3

Differences in oncogenic potency but not target cell specificity distinguish the two forms of the BCR/ABL oncogene.

Kelliher M, Knott A, McLaughlin J, Witte ON, Rosenberg N. Kelliher M, et al. Among authors: mclaughlin j. Mol Cell Biol. 1991 Sep;11(9):4710-6. doi: 10.1128/mcb.11.9.4710-4716.1991. Mol Cell Biol. 1991. PMID: 1875948 Free PMC article.

4

The 5' non-coding region of the BCR/ABL oncogene augments its ability to stimulate the growth of immature lymphoid cells.

Gishizky ML, McLaughlin J, Pendergast AM, Witte ON. Gishizky ML, et al. Among authors: mclaughlin j. Oncogene. 1991 Aug;6(8):1299-306. Oncogene. 1991. PMID: 1886706

5

Expression of a distinctive BCR-ABL oncogene in Ph1-positive acute lymphocytic leukemia (ALL).

Clark SS, McLaughlin J, Timmons M, Pendergast AM, Ben-Neriah Y, Dow LW, Crist W, Rovera G, Smith SD, Witte ON. Clark SS, et al. Among authors: mclaughlin j. Science. 1988 Feb 12;239(4841 Pt 1):775-7. doi: 10.1126/science.3422516. Science. 1988. PMID: 3422516

6

Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene.

Goga A, McLaughlin J, Afar DE, Saffran DC, Witte ON. Goga A, et al. Among authors: mclaughlin j. Cell. 1995 Sep 22;82(6):981-8. doi: 10.1016/0092-8674(95)90277-5. Cell. 1995. PMID: 7553858 Free article.

7

Signaling by ABL oncogenes through cyclin D1.

Afar DE, McLaughlin J, Sherr CJ, Witte ON, Roussel MF. Afar DE, et al. Among authors: mclaughlin j. Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9540-4. doi: 10.1073/pnas.92.21.9540. Proc Natl Acad Sci U S A. 1995. PMID: 7568169 Free PMC article.

8

Genetic approaches to defining signaling by the CML-associated tyrosine kinase BCR-ABL.

Afar DE, Goga A, Cohen L, Sawyers CL, McLaughlin J, Mohr RN, Witte ON. Afar DE, et al. Among authors: mclaughlin j. Cold Spring Harb Symp Quant Biol. 1994;59:589-94. doi: 10.1101/sqb.1994.059.01.067. Cold Spring Harb Symp Quant Biol. 1994. PMID: 7587117 Review. No abstract available.

9

Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene.

Sawyers CL, McLaughlin J, Witte ON. Sawyers CL, et al. Among authors: mclaughlin j. J Exp Med. 1995 Jan 1;181(1):307-13. doi: 10.1084/jem.181.1.307. J Exp Med. 1995. PMID: 7807010 Free PMC article.

10

Differential complementation of Bcr-Abl point mutants with c-Myc.

Afar DE, Goga A, McLaughlin J, Witte ON, Sawyers CL. Afar DE, et al. Among authors: mclaughlin j. Science. 1994 Apr 15;264(5157):424-6. doi: 10.1126/science.8153630. Science. 1994. PMID: 8153630

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,833 results

Search Page

Filters